REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 2 filers reported holding REDHILL BIOPHARMA LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7 | -100.0% | 51,000 | 0.0% | 0.00% | – |
| Q3 2022 | $26,000 | -40.9% | 51,000 | 0.0% | 0.00% | – |
| Q2 2022 | $44,000 | -77.2% | 51,000 | -33.3% | 0.00% | – |
| Q1 2022 | $193,000 | -51.0% | 76,500 | -50.0% | 0.00% | – |
| Q4 2021 | $394,000 | – | 153,000 | +1912400.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 8 | -90.7% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 86 | -31.2% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 125 | +25.0% | 0.00% | – |
| Q4 2020 | $1,000 | -98.0% | 100 | -99.1% | 0.00% | – |
| Q1 2020 | $51,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |